Immune History and Influenza Vaccine Effectiveness
- PMID: 29883414
- PMCID: PMC6027411
- DOI: 10.3390/vaccines6020028
Immune History and Influenza Vaccine Effectiveness
Abstract
The imperfect effectiveness of seasonal influenza vaccines is often blamed on antigenic mismatch, but even when the match appears good, effectiveness can be surprisingly low. Seasonal influenza vaccines also stand out for their variable effectiveness by age group from year to year and by recent vaccination status. These patterns suggest a role for immune history in influenza vaccine effectiveness, but inference is complicated by uncertainty about the contributions of bias to the estimates themselves. In this review, we describe unexpected patterns in the effectiveness of seasonal influenza vaccination and explain how these patterns might arise as consequences of study design, the dynamics of immune memory, or both. Resolving this uncertainty could lead to improvements in vaccination strategy, including the use of universal vaccines in experienced populations, and the evaluation of vaccine efficacy against influenza and other antigenically variable pathogens.
Keywords: imprinting; original antigenic sin; repeat vaccination; seasonal influenza vaccine; test-negative design; universal influenza vaccine; vaccine effectiveness.
Conflict of interest statement
The authors declare no conflict of interest. The sponsors had no role in the writing of the manuscript or in the decision to publish.
Figures
Similar articles
-
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.J Infect Dis. 2017 Dec 19;216(12):1487-1500. doi: 10.1093/infdis/jix526. J Infect Dis. 2017. PMID: 29029166 Free PMC article.
-
Seasonal influenza vaccines.Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Curr Top Microbiol Immunol. 2009. PMID: 19768400 Review.
-
Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains.mBio. 2021 Aug 31;12(4):e0044921. doi: 10.1128/mBio.00449-21. Epub 2021 Jul 6. mBio. 2021. PMID: 34225490 Free PMC article.
-
Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective.Vaccines (Basel). 2018 Apr 27;6(2):24. doi: 10.3390/vaccines6020024. Vaccines (Basel). 2018. PMID: 29702547 Free PMC article.
-
The Doctrine of Original Antigenic Sin: Separating Good From Evil.J Infect Dis. 2017 Jun 15;215(12):1782-1788. doi: 10.1093/infdis/jix173. J Infect Dis. 2017. PMID: 28398521 Free PMC article. Review.
Cited by
-
Next Generation Influenza Vaccines: Looking into the Crystal Ball.Vaccines (Basel). 2020 Aug 21;8(3):464. doi: 10.3390/vaccines8030464. Vaccines (Basel). 2020. PMID: 32825635 Free PMC article.
-
Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics.PLoS Pathog. 2019 Dec 19;15(12):e1008109. doi: 10.1371/journal.ppat.1008109. eCollection 2019 Dec. PLoS Pathog. 2019. PMID: 31856206 Free PMC article.
-
A Novel Sulfonated Derivative of β-Cyclodextrin Effectively Inhibits Influenza A Virus Infection in vitro and in vivo.Acta Naturae. 2019 Jul-Sep;11(3):20-30. doi: 10.32607/20758251-2019-11-3-20-30. Acta Naturae. 2019. PMID: 31720013 Free PMC article.
-
Measurement of Vaccine Direct Effects Under the Test-Negative Design.Am J Epidemiol. 2018 Dec 1;187(12):2686-2697. doi: 10.1093/aje/kwy163. Am J Epidemiol. 2018. PMID: 30099505 Free PMC article.
-
Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza Viral Infection.Viruses. 2019 Sep 10;11(9):840. doi: 10.3390/v11090840. Viruses. 2019. PMID: 31509992 Free PMC article.
References
-
- Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., Foust A., Lindstrom S., Shay D.K. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004–2005 season to the 2006–2007 season. J. Infect. Dis. 2009;199:159–167. doi: 10.1086/595861. - DOI - PubMed
-
- Zost S.J., Parkhouse K., Gumina M.E., Kim K., Perez S.D., Wilson P.C., Treanor J.J., Sant A.J., Cobey S., Hensley S.E. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc. Natl. Acad. Sci. USA. 2017;114:12578–12583. doi: 10.1073/pnas.1712377114. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources